Lp. Daggett et al., MOLECULAR AND FUNCTIONAL-CHARACTERIZATION OF RECOMBINANT HUMAN METABOTROPIC GLUTAMATE-RECEPTOR SUBTYPE-5, Neuropharmacology, 34(8), 1995, pp. 871-886
We have isolated and characterized overlapping cDNAs that encode two i
soforms of the human metabotropic glutamate receptor subtype 5 (hmGluR
5). The deduced amino acid sequences of human and rat mGluR5a are 94.5
% identical. However, a region in the putative cytoplasmic domain (SER
926-ALA1121) displays significant sequence divergence. Genomic analysi
s of this region showed that the sequence divergence results from spec
ies-specific differences in the genomic sequences, not from alternativ
e splicing. The distribution of mGluR5 mRNA in human brain was most st
rongly detected throughout the hippocampus, with moderate levels in th
e caudate-putamen, cerebral cortex, thalamus, and deep cerebellar nucl
ei, and at low levels in the cerebellar cortex. Activation of both hmG
luR5a and hmGluR5b transiently expressed in Xenopus oocytes and HEK293
cells was coupled to inositol phosphate (InsP) formation and elevatio
n of the intracellular free calcium ([Ca2+](i)). The agonist rank orde
r of potency for activating recombinant hmGluR5a receptors in either s
ystem was quisqualate > L-glutamate > IS,3R-ACPD. Both the quisqualate
stimulated InsP and [Ca2+](i) were inhibited by (+)-MCPG. Recombinant
human mGluR5a was also stably expressed in mouse fibroblast Ltk(-) ce
lls, in which the efficacy and potency of quisqualate were unchanged f
or more than 30 cell passages.